FDA recommends against all 7 peptides for the 503A Bulks List: • BPC-157 for ulcerative colitis • KPV, TB-500 for wound healing • MOTS-c for obesity and osteoporosis • Emideltide/DSIP for opioid withdrawal, insomnia, narcolepsy • Semax for stroke, migraine, pain • Epitalon for insomnia But a newly reconstituted Pharmacy Compounding Advisory Committee will weigh in at the July meeting. If they overrule staff, it opens the door to mainstream compounding pharmacies making these treatments available. Worth watching.